Carmell Therapeutics Corporation (CTCX) — Net Asset Quality Index
Carmell Therapeutics Corporation (CTCX) has a Net Asset Quality Index of -114.0% as of March 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.34 Million minus total liabilities of $7.14 Million yields net assets of $-3.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore how large is Carmell Therapeutics Corporation's balance sheet for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Carmell Therapeutics Corporation Net Asset Quality Index Over Time (2021–2024)
This chart shows how Carmell Therapeutics Corporation's Net Asset Quality Index has evolved across 4 annual periods from 2021 to 2024. As of March 2025, the index stands at -114.0%, representing net assets of $-3.81 Million against total assets of $3.34 Million USD. See CTCX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Carmell Therapeutics Corporation (2021–2024)
The table below presents the year-by-year Net Asset Quality Index for Carmell Therapeutics Corporation from 2021 to 2024, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Carmell Therapeutics Corporation (CTCX) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -319.7% | $-4.71 Million | $1.47 Million | $6.19 Million | ▼ -358.4 pp |
| 2023 | 38.7% | $24.75 Million | $63.95 Million | $39.20 Million | ▲ +2200.0 pp |
| 2022 | -2161.3% | $-37.79 Million | $1.75 Million | $39.54 Million | ▼ -261.8 pp |
| 2021 | -1899.5% | $-29.58 Million | $1.56 Million | $31.13 Million | — |